Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

137 evidences · page 6 / 6

57 %57% of individuals in the MIM profile had knowledge of the symptoms of COVID-19.

MaliCOVID-19HAL · Unilimdocument de 88 observations

29 %29% of individuals in the INO profile strongly agreed that COVID-19 was introduced by white people.

MaliCOVID-19HAL · Unilimdocument de 88 observations

9 deathsThe officially reported number of COVID-19 deaths in the Tombouctou population was 9.

MaliCOVID-19HAL · Unilimdocument de 88 observations

14,1 %The non-specific binding of antibody samples in COVID-19 patients accounted for 14.1% (12 out of 85) of the seroreactive samples for RBD and RBM.

MaliCOVID-19HAL · Unilimdocument de 67 observations

0,609 ODIn the COVID-19 patient group, the median optical density (OD) for anti-S antibody was 0.609 (Q1; Q3: 0.333; 1.260) in males and 0.712 (Q1; Q3: 0.339; 1.193) in females.

MaliCOVID-19HAL · Unilimdocument de 67 observations

0,174 ODIn the COVID-19 patient group, the median optical density (OD) for anti-RBM antibody was 0.174 (Q1; Q3: 0.130; 0.251) in males and 0.186 (Q1; Q3: 0.123; 0.300) in females.

MaliCOVID-19HAL · Unilimdocument de 67 observations

72 %Parmi les 1 164 patients inclus, 835 (72 %) remplissaient les critères de suspicion de COVID-19.

MaliCOVID-19observé June 2022 and September 2022HAL · Unilimdocument de 36 observations

Seroprevalence of SARS-CoV-2 was higher among older age groups in Tombouctou.

MaliCOVID-19HAL · Unilimdocument de 88 observations

0,76 %In Tombouctou health district, 532 confirmed cases of COVID-19 represented 0.76% of the general population.

MaliCOVID-19HAL · Unilimdocument de 88 observations

80,5 %Among COVID-19 patients (n = 266), 80.5% responded to the S antigen.

MaliCOVID-19HAL · Unilimdocument de 67 observations

33,5 %The seroprevalence of SARS-CoV-2 in the urban commune of Tombouctou was 33.5% (95% CI: 30.4% to 36.6%).

MaliCOVID-19observé January 2021HAL · Unilimdocument de 88 observations

33,5 %The crude seroprevalence of SARS-CoV-2 in Tombouctou was 33.5% (95% CI: 30.4% to 36.6%) among 923 tested individuals aged at least 1 year.

MaliCOVID-19observé January 2021HAL · Unilimdocument de 88 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.